XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Balance Sheets - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 27,568,114 $ 10,426,249
Inventory 918,651 918,651
Prepaid expenses and other assets 1,436,382 41,018
Total current assets 29,923,147 11,385,918
Other assets:    
Furniture and equipment, net 207,240 25,710
Patents, net 576,182 540,033
Other assets 2,174 2,174
Total other assets 785,596 567,917
Total Assets 30,708,743 11,953,835
Current liabilities:    
Accounts payable and accrued expenses 2,613,036 1,029,336
Notes payable, current 405,040 404,648
Royalty obligation 1,725,000 1,200,000
Total current liabilities 4,743,076 2,633,984
Long term liabilities:    
Notes payable 5,313,090 5,492,572
Convertible notes 1,300,000 1,300,000
Royalty obligation 1,813,000 2,638,000
Total long-term liabilities 8,426,090 9,430,572
Total liabilities 13,169,166 12,064,556
Commitments and Contingent Liabilities:
Redeemable preferred stock - subject to redemption: $0 par value; 20,000,000 shares authorized; 3,280,400 and 13,256,936 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively 820,099 3,314,233
Stockholders’ Equity (Deficit):    
Common stock and additional paid-in-capital: $0 par value, 500,000,000 shares authorized; and 79,217,056 and 66,295,288 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively 107,595,436 70,880,386
Accumulated deficit (90,875,958) (74,269,898)
Total stockholders’ equity (deficit) 16,719,478 (3,389,512)
Non-controlling interest (35,442)
Total equity (deficit) 16,719,478 (3,424,954)
Total Liabilities and Stockholders’ Equity (Deficit) $ 30,708,743 $ 11,953,835